Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Arens

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 5, 2024
Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative, -Low, and -Positive Metastatic Breast CancerBertha Eisses, Jasper J L van Geel, Adrienne H Brouwers, et al.
British Journal of Haematology|April 27, 2013
Comparison of modern and conventional imaging techniques in establishing multiple myeloma-related bone disease: a systematic reviewJosien C Regelink, Monique C Minnema, Evangelos Terpos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2025
Early [18F]FDG PET/CT Response after a Single Dose of Anti-EGFR Therapy as a Predictive Biomarker for Treatment Benefit in Patients with Advanced Colorectal CancerSophie L Gerritse, Erik J van Helden, Anne I J Arens, et al.
Plos One|July 1, 2025
[18F]FDG PET/CT to reduce the need for sentinel lymph node biopsy in early-stage oral cancer: PETN0-study protocolRoosmarijn S Tellman, Dominique N V Donders, Anne I J Arens, et al.
Leukemia|October 14, 2022
Prognostic value of TARC and quantitative PET parameters in relapsed or refractory Hodgkin lymphoma patients treated with brentuximab vedotin and DHAPJulia Driessen, Marie José Kersten, Lydia Visser, et al.
Cancer|July 8, 2020
Impact of optimizing diagnostic workup and reducing the time to treatment in head and neck cancerHenrieke W Schutte, Guido B van den Broek, Stefan C A Steens, et al.
Clinical and Translational Radiation Oncology|November 15, 2023
Personalized neck irradiation guided by sentinel lymph node biopsy in patients with squamous cell carcinoma of the oropharynx, larynx or hypopharynx with a clinically negative neck: (Chemo)radiotherapy to the PRIMary tumor only. Protocol of the PRIMO studyS van den Bosch, R P Takes, M de Ridder, et al.
JAMA Oncology|April 16, 2026
18F-Fluorodeoxyglucose Positron Emission Tomography for Estimating Outcomes After Initial Treatment for Metastatic Breast Cancer: A Nonrandomized Clinical Cohort TrialJasper J L van Geel, Bertha Eisses, Sjoerd G Elias, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2022
[89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell CarcinomaSarah R Verhoeff, Sjoukje F Oosting, Sjoerd G Elias, et al.
Haematologica|December 1, 2020
Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trialMartine E D Chamuleau, Coreline N Burggraaff, Marcel Nijland, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 5, 2024
Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative, -Low, and -Positive Metastatic Breast CancerBertha Eisses, Jasper J L van Geel, Adrienne H Brouwers, et al.
British Journal of Haematology|April 27, 2013
Comparison of modern and conventional imaging techniques in establishing multiple myeloma-related bone disease: a systematic reviewJosien C Regelink, Monique C Minnema, Evangelos Terpos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2025
Early [18F]FDG PET/CT Response after a Single Dose of Anti-EGFR Therapy as a Predictive Biomarker for Treatment Benefit in Patients with Advanced Colorectal CancerSophie L Gerritse, Erik J van Helden, Anne I J Arens, et al.
Plos One|July 1, 2025
[18F]FDG PET/CT to reduce the need for sentinel lymph node biopsy in early-stage oral cancer: PETN0-study protocolRoosmarijn S Tellman, Dominique N V Donders, Anne I J Arens, et al.
Leukemia|October 14, 2022
Prognostic value of TARC and quantitative PET parameters in relapsed or refractory Hodgkin lymphoma patients treated with brentuximab vedotin and DHAPJulia Driessen, Marie José Kersten, Lydia Visser, et al.
Cancer|July 8, 2020
Impact of optimizing diagnostic workup and reducing the time to treatment in head and neck cancerHenrieke W Schutte, Guido B van den Broek, Stefan C A Steens, et al.
Clinical and Translational Radiation Oncology|November 15, 2023
Personalized neck irradiation guided by sentinel lymph node biopsy in patients with squamous cell carcinoma of the oropharynx, larynx or hypopharynx with a clinically negative neck: (Chemo)radiotherapy to the PRIMary tumor only. Protocol of the PRIMO studyS van den Bosch, R P Takes, M de Ridder, et al.
JAMA Oncology|April 16, 2026
18F-Fluorodeoxyglucose Positron Emission Tomography for Estimating Outcomes After Initial Treatment for Metastatic Breast Cancer: A Nonrandomized Clinical Cohort TrialJasper J L van Geel, Bertha Eisses, Sjoerd G Elias, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2022
[89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell CarcinomaSarah R Verhoeff, Sjoukje F Oosting, Sjoerd G Elias, et al.
Haematologica|December 1, 2020
Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trialMartine E D Chamuleau, Coreline N Burggraaff, Marcel Nijland, et al.
Pageof 9